LASIK could now be possible in patients previously excluded

Article

Epithelial thickness profiles may make it possible for LASIK to be performed in eyes that may otherwise have been excluded because of topographic suspect keratoconus.

Epithelial thickness profiles may make it possible for LASIK to be performed in eyes that may otherwise have been excluded because of topographic suspect keratoconus, according to Dan Reinstein and colleagues from the London Vision Clinic, London, UK.

In his study, eyes suspected of keratoconus were scanned with Artemis very high-frequency (VHF) digital ultrasound. A diagnosis was confirmed if the epithelial thickness profile demonstrated relative epithelial thinning coincident with the topographically suspected cone.

LASIK was then performed in all eyes where keratoconus was excluded by finding relatively thicker epithelium over the topographically suspected cone. Patients were followed for one year and a matched control group was randomly generated to compare refractive outcomes.

Out of a total of 1,352 consecutive myopic eyes, 104 (7.7%) were classified as keratoconus suspects. After Artemis scanning, 14 eyes (17%) were confirmed as having keratoconus and 90 eyes (40 subjects) were found to be non-keratoconic and underwent LASIK. A control for each study eye was matched within 0.50 D for sphere, cylinder and spherical equivalent (SE). The average change in SE between three months and one-year follow-up was -0.03 D for the keratconus suspect group and -0.09 D for the control group.

The researchers concluded that epithelial thickness profiles may allow LASIK to be performed in eyes that, in the past, would have been excluded because of topographic suspect keratoconus.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.